Pteryxin
APC-507
Pteryxin
Cat. No.
APC-507
CAS No.
13161-75-6
MF
C21H22O7
MW
386.4
Pteryxin is a BChE inhibitor.
Need help? Our team of experienced experts is here for you with full support.
Technical Data
Description
Storage and Shipping
References
Product Name
CAS No.
13161-75-6
MF
C21H22O7
MW
386.4
Specification
98%
Research Area
Anti-inflammatory, antioxidant, osteoclastogenesis inhibitory
Description
Pteryxin is a BChE inhibitor. Packing: 10mg, 20mg, 50mg, 100mg, 500mg, 1g, 5g, 10g Availability: In stock
Storage and Shipping
Store under frozen or refrigerated conditions, keep away from strong light and heat
References
[1]. Zhen D, et al. Pteryxin attenuates LPS-induced inflammatory responses and inhibits NLRP3 inflammasome activation in RAW264.7 cells. J Ethnopharmacol. 2022 Feb 10;284:114753.
[2]. Sun R, et al. Pteryxin suppresses osteoclastogenesis and prevents bone loss via inhibiting the MAPK/Ca2+ signaling pathways mediated by ROS. Biomed Pharmacother. 2023 Sep;165:114898.
[3]. Taira J, et al. Cytoprotective Effect of Pteryxin on Insulinoma MIN6 Cells Due to Antioxidant Enzymes Expression via Nrf2/ARE Activation. Antioxidants (Basel). 2023 Mar 10;12(3):693.
Disclaimer
This product is intended solely for scientific research or regulatory filing purposes. We do not provide products or services to individuals, please strictly comply with all applicable laws, regulations, and the committed use. Use for any other purpose is strictly prohibited.
Related Products
* Some statements have not been evaluated by national authorities. * Some products are not intended to diagnose, treat, cure, or prevent any disease. * For literature supporting, please contact us directly.